PCV169 ACETYLSALICYLIC ACID(ASA) MONOTHERAPY FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: AN ASSESSMENT OF THE MEDICAL BENEFIT USING THE IQWIG METHODOLOGICAL APPROACH
S Maxion-Bergemann, F Hessel, ES DietrichVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74695-7
File:
PDF, 71 KB
english, 2009